MAVERICK CAPITAL LTD

Position in NVO — Novo Nordisk A S

CIK 934639 DALLAS, TX

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$79,286,623

+$2,842,177 QoQ

Shares Held

1,653,872

-20.5% QoQ

Ownership

0.037%

of shares outstanding

% of Portfolio

0.72%

of 13F equity value

Holder Rank

#41

of 1,348 holders

Holding Since

Sep 2020

9 quarters on record

Healthcare · as of Jun 30, 2026

MAVERICK CAPITAL LTD holds $85,841,776 across 3 Drug Manufacturers - General names. NVO ranks #1 (92.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVO	Novo Nordisk A S This page	1,653,872	$79,286,623
2	NVS	Novartis AG	27,789	$4,355,092
3	SNY	Sanofi	51,572	$2,200,061

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$79,286,623	1,653,872	-20.5%	Shares	Sole	2026-08-14
2026-03-31	$76,444,446	2,080,121	+26401.7%	Shares	Sole	2026-05-15
2024-06-30	$1,120,366	7,849	+272.9%	Shares	Sole	2024-08-14
2024-03-31	$270,282	2,105	-2.4%	Shares	Sole	2024-05-15
2023-03-31	$343,105	2,156	-6.4%	Shares	Sole	2023-05-15
2022-12-31	$311,823	2,304	-6.9%	Shares	Sole	2023-02-16
2022-09-30	$246,584	2,475	-6.9%	Shares	Sole	2022-11-14
2020-12-31	$185,661	2,658	-70.2%	Shares	Sole	2021-02-16
2020-09-30	$620,218	8,933	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.